Back to BlackRock, Inc. BlackRock, Inc.

ADAPYADAPY
5 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs

BlackRock, Inc. previously held 0 shares of ADAPY (ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$98,951

Total Shares Change

-183,686

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$0.03
0
2025-Q3
Decreased
38,296
-78.6%
$4,9780.0%$0.14
0
2025-Q2
Decreased
179,087
-2.5%
$42,9270.0%$0.25
0
2025-Q1
Unchanged
183,686
0.0%
$36,1860.0%$0.21
0
2024-Q4
New
183,686
-
$98,9510.0%$0.55
33

Other major holders of ADAPY: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used